NCT06400888View on ClinicalTrials.gov

Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Diabetic Peripheral Neuropathy
Interventions
OTHER

needle-free subcutaneous injector for Mecbl

needle-free subcutaneous injector for Mecbl

OTHER

intramuscular injection of Mecbl

intramuscular injection of Mecbl

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT06400888 - Needle-Free Subcutaneous Injector and Conventional Intramuscular Injection of Mecobalamin in Diabetes Peripheral Neuropathy | Biotech Hunter | Biotech Hunter